Drug Discovery Informatics Market Size, Share, Trends, Growth and Forecast 2032

Drug Discovery Informatics Market Insights

According to a report from Zion Market Research, the global Drug Discovery Informatics Market was valued at USD 3.38 Billion in 2023 and is projected to hit USD 11.19 Billion by 2032, with a compound annual growth rate (CAGR) of 14.22% during the forecast period 2024-2032.

This report explores market strengths, weakness, opportunities, and threats. It also provides valuable insights into the market's growth drivers, challenges, and the future prospects that may emerge in the Drug Discovery Informatics Market industry over the next decade.

Request Free Sample

Drug Discovery Informatics Market Size Overview     

The drug discovery informatics market is about to realize momentum within the coming years owing to advancements in high-performance computing & web services, the growing volume of drug discovery data, the growing adoption of in-silico modeling tools, and the increasing demand for novel medicine moieties. The launch of advanced drug discovery information technology is about to accentuate the industry competition. For Instance, in January 2021, Certara, Inc. launched Simcyp Physiologically-based Pharmacokinetic (PBPK) Simulator platform version 20. The new models help in analyzing and assessing drug action during lactation and pregnancy.

Request Free Sample

In addition, it helps the purchasers with critical decisions regarding optimizing medication safety and efficacy profile. Companies also are increasingly adopting informatics solutions to shorten the long drug discovery timeline. as an example, in December 2020, Curve Therapeutics Ltd. implemented the CDD Vault platform for handling its genetically encoded Microcycle platform. it's a ubiquitous hosted platform suitable for applications across, biotechnology, pharmaceutical & academic institutes for securing and seamless sharing of knowledge in real-time, thereby facilitating collaborative discoveries.

COVID-19 Impact Analysis  

The impact of COVID-19 is supposed to be for a short range; however, its impact going to have a vast effect on the drug discovery companies, forecast to have a big scope for a minimum of a year to 12-15 months. This led to organizations capitalizing more on solutions and services to endure operations. Governments are declaring packages to assist businesses during this pandemic, with a special specialization in Small & Medium-scale Enterprises. Besides, the accelerated Covid-19 drug discovery around the world is supplementarily contributing to the market growth. For instance, providing fast-track solutions, scientists executed virtual screening using medicine from the DrugBank, for targeting the viral proteins and human ACE2 receptors. These studies were supported in silico tools for screening small molecules that have the likely usage in drug discoveries against Covid-19.

Companies are also developing several web services & solutions for supporting various steps of drug development for Covid-19. For example, in June 2020, the IBM visual molecular explorer platform explored a specific set of the generated molecules targeting the coronavirus (SARS-CoV-2). The open-source sharing of the AI-generated artifacts within the explorer helped within the initial stages of optimal medicine designing.

Request Free Sample

Global Drug Discovery Informatics Market Size: Growth Factors

Market growth is essentially driven by factors like the increasing R&D expenditure, budding support for research, particularly within the area of rare diseases, and therefore the growing use of informatics in drug discovery. Players across the drug discovery informatics market are concentrating aggressively on innovation, also on including advanced technologies in their existing products. Over the approaching years, they're also expected to require partnerships and mergers & acquisitions as their key strategy for business development. However, the scarcity of expert professionals and so the high setup cost of informatics Outsourced Informatics is anticipated to limit market growth to a particular extent.

Drug Discovery Informatics Market: Report Scope

Mode Segment Analysis Preview  

The outsourced segment will expand further at a gentle CAGR during the forecast period on account of an increasing number of partnerships between pharmaceutical companies & contract development and manufacturing organizations. Contract Research Organizations are involved in the creation of reports on new drug entities that are subsequently employed by the drug manufacturer/sponsor for submission to the U.S. FDA. There are benefits when pharmaceutical & biotechnology companies partner with a CRO that has an equivalent informatics solution. The shared informatics platform between the CRO and corporations helps in monitoring the progress of studies in the same way as their internal studies. This helps the corporate in cost-saving and productivity gain, which is predicted to supply the market entities with immense profitable opportunities.

Request Free Sample

Service Segment Analysis Preview  

The informatics platform enables users to rearrange peptide sequences supported by code by property. Molecular modeling is progressively gaining popularity due to its wide application within the drug discovery process. These tools are applied for the modeling & simulation of biological systems and little molecules for understanding & forecasting their behavior at a molecular level. Additionally, they accelerate the cost-efficiency of hit discovery and hit-to-lead optimization.

Regional Segment Analysis Preview  

Globally, North America has been leading the worldwide drug discovery informatics market and is expected to continue in the dominant position within the years to return, followed by Europe. Growing penetration of in-silico technologies also their rampant use witnessed within the region is the key factor behind the dominance of the North American drug discovery informatics market. The high number of market players headquartered in North America is another significant factor that's supporting this regional market. APAC drug discovery informatics market is expected to witness swift growth, due to the growing presence of pharmaceutical firms alongside the increasing occurrence of cancer ailments in most populated countries like India and China.

Request Free Sample

Key Market Players & Competitive Landscape

The key players profiled in the report include-

• Certara
• Boehringer Ingelheim International GmbH
• Infosys Ltd.
• Charles River Laboratories
• Collaborative Drug Discovery
• Eurofins DiscoverX Products
• Jubilant Biosys
• Selvita
• Novo Informatics Pvt. Ltd.
• ChemAxon Ltd.
• Albany Molecular Research Inc.
• Oracle
• Accenture
• Agilent Technologies
• Illumina
• amongst others.

The global Drug Discovery Informatics is segmented as follows:

By Mode

• Outsourced Informatics
• In-House Informatics

By Services

• Docking
• Modular Modeling

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of the Middle East & Africa